Search Results
Results found for "Structure Therapeutics"
- Angiotensin-(1-7) improves cognitive function and reduces inflammation in mice following mild trauma
This study examined the therapeutic effect of Ang-(1-7) on secondary injury observed in a murine model
- Discovery of 3(2-aminoethyl)-thiazolidine-2,4-diones as a novel chemotype of sigma-1 receptor ligand
hydrophobic groups of different sizes on both sides of the five-membered ring scaffold guided by the crystal structure
- Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted drug discovery
In summary, targeting GPCR-activated ERK pathways represents a promising strategy for developing new therapeutics ERK-dependent apoptosis as a potential therapeutic strategy for cancer. Cells, 10(10), 2509.
- Lysine 101 in the CRAC Motif in Transmembrane Helix 2 Confers Cholesterol-Induced Thermal...
We envision that our results could have potential implications in structural biological advancements
- Neuropeptide S Encodes Stimulus Salience in the Paraventricular Thalamus
PVT NPSR1 neurons recruit the nucleus accumbens shell and structures in the prefrontal cortex and amygdala
- New Resources in GPCRdb
present and demonstrate the newest resources of the GPCRdb: 1) the new G protein resources and 2) the structural
- 📰 GPCR Weekly News, January 15 to 21, 2024
procerum Editorial: Advanced biophysical and biochemical technologies to study GPCR signal transduction Structural Clinical Pharmacology 2026 GPCR Jobs NEW Post-Doc position NEW Lead Researcher Senior Researcher in Structural
- Focusing on the role of secretin/adhesion (Class B) G protein-coupled receptors in placental...
of membrane proteins in eukaryotes and the largest drug target family to date, exhibit diversity in structure
- Expression pattern and clinical significance of beta 2-adrenergic receptor in oral squamous cell...
2-adrenergic receptor in oral squamous cell carcinoma: an emerging prognostic indicator and future therapeutic
- Reversible Photocontrol of Dopaminergic Transmission in Wild-Type Animals
animals and opens the way to remotely controlling dopaminergic neurotransmission for fundamental and therapeutic
- Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery
These nuances define therapeutic potential and side-effect risk. Each mode reshapes both potency and therapeutic window.
- Exploring pharmacological inhibition of G q/11 as an analgesic strategy
These can be used either as stand-alone therapeutics or to improve the safety profile of opioid drugs
- Biotech Startup Failure: Why Teams Drift Off Course Without a Single Wrong Decision
By the time leadership senses friction, the underlying causes are already structural. 👉 Biotech startup It is structural. 👉 Biotech startup failure of this kind is difficult to spot precisely because nothing
- G protein-coupled receptor interactions and modification of signalling involving the ghrelin ...
GHSR1a The growth hormone secretagogue receptor 1a (GHSR1a) is intriguing because of its potential as a therapeutic Initial studies of the receptor focused on the potential therapeutic ability for growth hormone (GH)
- TeachOpenCADD - A teaching platform for computer-aided drug design
Open source programming packages for cheminformatics and structural bioinformatics are powerful tools
- Crinetics Pharmaceuticals Expands Executive Team With Appointment Of James Hassard As Chief ...
stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics
- APEX2/AUR Biosensor: A Powerful Tool for Protein Interaction and Trafficking
; understanding the role of DNAJC13 in GPCR trafficking could profoundly affect the development of therapeutic
- Intermolecular Interactions in G Protein-Coupled Receptor Allosteric Sites at the Membrane Interface
binding location that raises many questions about the ligand interactions and stability, the binding site structure
- An overview of the compartmentalized GPCR Signaling: Relevance and Implications
compartments and signaling pathways associated with GPCRs holds promise for the development of novel therapeutic Insights into Nuclear G-Protein-Coupled Receptors as Therapeutic Targets in Non-Communicable Diseases GPCRomics: GPCR Expression in Cancer Cells and Tumors Identifies New, Potential Biomarkers and Therapeutic
- A central alarm system that gates multi-sensory innate threat cues to the amygdala
The identification of unified innate threat pathways may provide insights into developing therapeutic
- Crinetics Pharmaceuticals Announces Pricing Of Underwritten Common Stock Offering
clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics
- Dynamic recognition of naloxone, morphine and endomorphin1 in the same pocket of µ-opioid receptors
relieves severe pain by activating the μ-opioid receptor (MOR), whereas naloxone, with only slight structural
- Deciphering the signaling mechanisms of β-arrestin1 and β-arrestin2 in regulation of cancer cell...
Understanding these processes has important implications for understanding the therapeutic intervention
- Orion Shares New Data on its Latest Best-in-Class Drug Candidate
10, 2022 — Orion Biotechnology Canada Ltd, a drug discovery and development company unlocking the therapeutic
- Immunomodulatory Role of Neuropeptides in the Cornea
maintaining the homeostasis of the ocular surface, alterations in disease settings, and the possible therapeutic
- Latrophilin-1 drives neuron morphogenesis and shapes chemo- and mechanosensation-dependent ...
Here, we show that Latrophilin-1 acts in trans to mediate morphogenesis of sensory structures in the
- Chronic itch: emerging treatments following new research concepts
itch processing, the numerous mediators and receptors involved has led to a large variety of possible therapeutic
- Orion Announces The Rapid Lead Optimization Of Ob-004 - A Ccr2 Antagonist
Ottawa, Ontario, Canada, Nov. 30, 2021 -- Orion Biotechnology, a clinical stage company unlocking the therapeutic
- Lipid Modulation of a Class B GPCR: Elucidating the Modulatory Role of PI(4,5)P 2 Lipids
interacting with the Glucagon receptor (GCGR), which constitutes an important target for diabetes and obesity therapeutics
- Reflections on My PhD Journey: Lessons Learned
is simple: choose a lab and mentor that align with your values and goals, embrace the discipline of structured



